<?xml version="1.0" encoding="UTF-8"?>
<p>The Medical Cannabis Network of Israel also reports that a current study is being undertaken by researchers at the Israel Institute of Technology investigating the therapeutic efficacy of a cannabis terpene inhalant formulation in suppressing the immune system response against COVID-19 [
 <xref rid="B37-molecules-26-00607" ref-type="bibr">37</xref>]. A molecular docking analysis also reported the antiviral activity of Ginkgolide A, a terpenoid produced by the 
 <italic>Ginkgo biloba</italic> tree, against COVID-19 [
 <xref rid="B38-molecules-26-00607" ref-type="bibr">38</xref>].
</p>
